Accenture plc (ACN)
Quantitative Summary
DeterministicAt 15.3x earnings — a 76% discount to the sector average of 65.0x — ACN is in the lower valuation range. Financial health is average: Piotroski 5/9, Altman Z 4.2. DCF fair value of $240 implies 25% upside from current prices based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedAccenture plc demonstrates robust fundamental economics characterized by a 18.4% return on invested capital, which generates a meaningful +6.2% spread over the cost of equity at 12.2%. The DuPont decomposition reveals that this efficiency is driven primarily by high operating leverage and asset utilization rather than margin expansion or excessive debt; specifically, an 11.0% net margin combined with a 1.07x asset turnover and a 2.03x equity multiplier yields a healthy 23.8% return on equity. Credit risk metrics further support this quality profile, as the Altman Z-Score of 4.5 indicates low bankruptcy probability while the Beneish M-Score of -2.73 suggests earnings are unlikely to be inflated, though the Piotroski F-Score of 5/9 reflects moderate financial strength without recent aggressive improvement signals.
Despite these operational strengths, valuation metrics present a distinct divergence from sector norms and intrinsic models. The current price-to-earnings ratio of 16.5x trades at approximately 60% below the technology sector average of 42.2x, creating an apparent discount relative to peers. This compression contrasts sharply with a discounted cash flow analysis that implies fair value at $237, suggesting potential upside if market sentiment aligns closer to long-term free cash flow growth expectations of roughly 3.2% annually over the next decade. The pricing gap may reflect broader macro concerns or specific sector headwinds rather than company-specific deterioration, as profitability factors remain robust with a positive RMW score of 0.103.
However, risk-adjusted performance indicators and insider activity warrant close scrutiny before concluding on valuation attractiveness. The stock exhibits significant negative momentum relative to the Fama-French three-factor model, recording an annual alpha of -62.42%, which implies underperformance after adjusting for market, size, and value exposures. This growth tilt is further complicated by a Value Factor (HML) of -0.153, indicating the stock behaves more like a growth asset than a traditional value play despite its low multiple. Compounding these headwinds, insider flow over the last 90 days shows net selling totaling $7.7 million, signaling potential caution from those closest to the business operations amidst this valuation discrepancy.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 7% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 10% | 12% | 14% |
|---|---|---|---|
| 2% | $278 | $223 | $187 |
| 3% | $308 | $240 | $197 |
| 4% | $346 | $261 | $210 |
Center = base case. Green = >10% upside, Red = >10% downside vs $186.22.
Pre-computed DCF: WACC=12.0%, terminal growth 3%. Fair value $240 (+25.2%). Not investment advice.
Valuation Context
Currently trading 30% below its 5-year average P/E of 20.9x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedAccenture plc is currently trading at $179.24 within the technology sector, presenting a snapshot where price action intersects with broader market volatility dynamics. The specific drawdown magnitude relative to recent peaks suggests that any upward momentum may be testing structural support levels rather than indicating an irreversible trend shift. Without additional volume data or moving average crossovers, it remains unclear whether current fluctuations represent a healthy consolidation phase or the early stages of a deeper correction driven by sector-specific headwinds. The fundamental backdrop for technology giants often involves high sensitivity to interest rate environments and enterprise IT spending cycles; consequently, price movements in this range frequently reflect recalibration of valuation models rather than pure operational news. If volatility spikes while prices stagnate near these levels, it could signal fragile momentum where small catalysts trigger disproportionate reactions. Conversely, sustained trading above key psychological thresholds might imply a more resilient underlying demand structure despite the visible drawdown. Ultimately, the current technical configuration highlights a tension between established valuation anchors and short-term price weakness. Observers should monitor whether subsequent sessions can reclaim lost ground or if further erosion occurs, as this will determine if the present setup is merely a pause in an uptrend or a pivot point toward lower valuations. The interplay of these factors underscores the need for caution when interpreting immediate directional bias without confirming broader trend integrity through extended observation periods.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-04-09 | $1.6300 | +10.1% |
| 2025-07-10 | $1.4800 | 0.0% |
| 2025-04-10 | $1.4800 | 0.0% |
| 2025-01-16 | $1.4800 | 0.0% |
| 2024-10-10 | $1.4800 | +14.7% |
| 2024-07-11 | $1.2900 | 0.0% |
| 2024-04-10 | $1.2900 | 0.0% |
| 2024-01-17 | $1.2900 | 0.0% |
| 2023-10-11 | $1.2900 | +15.2% |
| 2023-07-12 | $1.1200 | 0.0% |
| 2023-04-12 | $1.1200 | 0.0% |
| 2023-01-11 | $1.1200 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like SDY or VFQY, the fund manager is mechanically forced to buy or sell ACN shares regardless of Accenture plc's individual fundamentals. We estimate $11.3B of passive capital is structurally linked to ACN through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Accenture plc to visualize passive redemption contagion across ETFs and collateral stocks.
If Accenture plc (ACN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA CORP (NVDA) as the most exposed collateral stock, sharing 1 ETFs with ACN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 23 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
ACN Ownership Dynamics
Passive funds hold 1 in every 9 ACN shares, reducing daily market volatility.
Accenture plc (ACN) exerts measurable gravity on the passive index market, currently representing 1.3% of the SDY (SDY) and 1.0% of the VFQY (VFQY). Across 23 tracked ETFs, approximately 69M shares (11.2% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest ACN Exposure
Float lock-up computed from 23 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
ACN Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Accenture plc over the past year sits near $242.10 (15% of 252-day volume). The current price of $186.22 sits 23.1% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level. The highly concentrated volume profile (15% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
ACN Capital Efficiency
How efficiently does Accenture plc convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Accenture plc converts 92% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 6.4% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 68 | $159.64 | $10,855.52 |
| 2026-05-06 | 70,702 | $179.01 | $12.7M |
| 2026-05-01 | 1,784 | $178.71 | $318,818.64 |
| 2026-04-27 | 766 | $178.36 | $136,623.76 |
| 2026-04-20 | 100 | $197.65 | $19,765 |
| 2026-04-15 | 3 | $190.37 | $571.11 |
| 2026-04-10 | 19 | $186.03 | $3,534.57 |
| 2026-04-09 | 12,034 | $193.84 | $2.3M |
| 2026-04-06 | 4,735 | $201.33 | $953,297.55 |
| 2026-03-26 | 383 | $192.29 | $73,647.07 |
| 2026-03-25 | 68 | $193.54 | $13,160.72 |
| 2026-03-24 | 17 | $200.02 | $3,400.34 |
| 2026-03-23 | 3 | $199.99 | $599.97 |
| 2026-03-16 | 163 | $196.65 | $32,053.95 |
| 2026-03-10 | 88,033 | $209.36 | $18.4M |
| 2026-03-06 | 703 | $214.00 | $150,442 |
| 2026-03-05 | 703 | $210.00 | $147,630 |
| 2026-03-02 | 100 | $208.72 | $20,872 |
| 2026-02-26 | 6,070 | $191.50 | $1.2M |
| 2026-02-23 | 3,007 | $215.35 | $647,557.45 |
| 2026-02-13 | 5,000 | $222.05 | $1.1M |
| 2026-02-11 | 96 | $240.86 | $23,122.56 |
| 2026-02-10 | 47,337 | $236.76 | $11.2M |
| 2026-02-09 | 34,500 | $240.62 | $8.3M |
| 2026-01-20 | 2 | $286.21 | $572.42 |
| 2026-01-14 | 21,837 | $276.80 | $6.0M |
| 2026-01-13 | 160 | $280.96 | $44,953.6 |
| 2026-01-12 | 200 | $280.67 | $56,134 |
| 2026-01-08 | 370 | $273.98 | $101,372.6 |
| 2026-01-05 | 32 | $259.95 | $8,318.4 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| EPAM | 0.681 | 0.713 | Moderate |
| PAYX | 0.621 | 0.705 | Moderate |
| ADP | 0.609 | 0.674 | Moderate |
| WDAY | 0.566 | 0.609 | Moderate |
| GEN | 0.550 | 0.636 | Moderate |
| ADBE | 0.544 | 0.579 | Moderate |
| TENB | 0.542 | 0.535 | Moderate |
| CRM | 0.541 | 0.529 | Moderate |
| FIS | 0.540 | 0.620 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare ACN to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.